High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
Open Access
- 8 June 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 10 (8), 1500-1507
- https://doi.org/10.1111/j.1538-7836.2012.04812.x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul StudyAmerican Heart Journal, 2011
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities StudyCirculation, 2011
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed TomographyCirculation, 2010
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseThe New England Journal of Medicine, 2009
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2008
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic ReviewPLoS Medicine, 2008
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart FailureCirculation, 2007
- Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillationAmerican Heart Journal, 2004
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991